New Vital Pulpotomy Medications in Primary Molars

Carious Exposure of Pulp Clinical Trial

Official title:
Clinical and Radiographic Evaluation of Hyaluronic Acid and Biodentine as Vital Pulpotomy Medications in Primary Molars: Randomized Controlled Clinical Trial

Status Active, not recruiting

Clinical Trial Summary

Evaluate clinically and radiographically the effect of biodentine and hyaluronic acid (HA) versus formocresol (FC) as pulpotomy medications in primary molars.

Clinical Trial Description

Split mouth randomized controlled clinical trial. This study will be conducted on 96 teeth from 48 children in age group 4-7 years and have bilateral lower primary molars indicated for vital pulpotomy procedure. for: 1. Clinical evaluation of biodentine, hyaluronic acid and formocresol groups according to presence of failure criteria at different follow up periods. 2. Radiographic evaluation of biodentine, hyaluronic acid and formocresol groups according to presence of failure criteria at different follow up periods. ;

Study Design

Related Conditions & MeSH terms

Carious Exposure of Pulp

Clinical Trial Details

NCT number	NCT05937100
Study type	Interventional
Source	Mansoura University
Contact
Status	Active, not recruiting
Phase	N/A
Start date	May 1, 2023
Completion date	November 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05479877` - A Comparative Clinical and Radiographic Study of Collagen Based Pulpotomy Versus Biodentine Pulpotomy in Children With Cariously Exposed Vital Primary Molars	Early Phase 1
Not yet recruiting	`NCT06378814` - Outcome of Selective & Nonselective Caries Removal in Permanent Teeth	N/A
Recruiting	`NCT05279820` - Comparative Study of the Outcome of Partial and Full Pulpotomy in Irreversible Pulpits	N/A
Completed	`NCT03838094` - Evaluation of MTA Versus Biodentine as Pulpotomy Agents in Immature First Permanent Molars	Phase 1/Phase 2